Last May the World Health Assembly passed a ground-breaking resolution endorsing the Global Vaccine Action Plan (GVAP), a roadmap to achieve ambitious immunization goals, making this decade the “Decade of Vaccines.”
A new public-private partnership of the Japanese Government, the Bill &Melinda Gates Foundation and a group of private pharmaceutical companies seeks to foster and harness Japanese innovation to address diseases that disproportionately affect low- and middle-income countries.
The flattening in support for biomedical research as well as other research fields in the United States over the last decade is having serious consequences for American science and scientists. Ultimately, we need a new generation of scientist-advocates and policy experts if we expect to reverse this trend.
The disease’s economic burden meets or exceeds that of rotavirus, Lyme disease and cervical cancer